These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6273376)

  • 1. Interaction of beta-lactamase of Streptomyces cacaoi. II. CP-45,899, izumenolide and cephamycins.
    Mantoku A; Ogawara H
    J Antibiot (Tokyo); 1981 Oct; 34(10):1347-50. PubMed ID: 6273376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of beta-lactamase of Streptomyces cacaoi. I. Clavulanic acid and PS-5.
    Ogawara H; Mantoku A
    J Antibiot (Tokyo); 1981 Oct; 34(10):1341-6. PubMed ID: 6975771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME; Fu KP; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(3):145-8. PubMed ID: 3040368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-lactamase of Streptomyces cacaoi: interaction with cefoxitin and beta-iodopenicillanate.
    Lenzini MV; Frère JM
    J Enzyme Inhib; 1985; 1(1):25-34. PubMed ID: 2854843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrophotometric determination of inhibitory effects of CP-45899 on beta-lactamase with benzylpenicillin and nitrocefin.
    Yamabe S
    J Antimicrob Chemother; 1980 May; 6(3):420-1. PubMed ID: 6249784
    [No Abstract]   [Full Text] [Related]  

  • 6. Bactericidal activity of cefoperazone with CP-45,899 against large inocula of beta-lactamase-producing Haemophilus influenzae.
    Yu PK; Washington JA
    Antimicrob Agents Chemother; 1981 Jul; 20(1):63-5. PubMed ID: 6269484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.
    Matagne A; Ghuysen MF; Frère JM
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):705-11. PubMed ID: 8240281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
    Fu KP; Neu HC
    J Antimicrob Chemother; 1981 Mar; 7(3):287-92. PubMed ID: 6268598
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic study of NMC-A beta-lactamase, an Ambler class A carbapenemase also hydrolyzing cephamycins.
    Mariotte-Boyer S; Nicolas-Chanoine MH; Labia R
    FEMS Microbiol Lett; 1996 Sep; 143(1):29-33. PubMed ID: 8807798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Izumenolide-a novel beta-lactamase inhibitor produced by Micromonospora. II. Biological properties.
    Bush K; Bonner DP; Sykes RB
    J Antibiot (Tokyo); 1980 Nov; 33(11):1262-9. PubMed ID: 6972939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-lactamase from Streptomyces cacaoi. Purification and properties.
    Ogawara H; Mantoku A; Shimada S
    J Biol Chem; 1981 Mar; 256(6):2649-55. PubMed ID: 6970744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotetan and beta-lactamases. II. An unusual property: the inactivation of some beta-lactamases by cefotetan.
    Labia R; Morand A; Peduzzi J
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():153-7. PubMed ID: 6601655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. I. Inhibition of chromosomally and R-factor-mediated beta-lactamases.
    Arisawa M; Then RL
    J Antibiot (Tokyo); 1982 Nov; 35(11):1578-83. PubMed ID: 6298167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional induction of Streptomyces cacaoi beta-lactamase by a beta-lactam compound.
    Forsman M; Lindgren L; Häggström B; Jaurin B
    Mol Microbiol; 1989 Oct; 3(10):1425-32. PubMed ID: 2559297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and amplified expression in Streptomyces lividans of the gene encoding the extracellular beta-lactamase from Streptomyces cacaoi.
    Lenzini MV; Nojima S; Dusart J; Ogawara H; Dehottay P; Frere JM; Ghuysen JM
    J Gen Microbiol; 1987 Oct; 133(10):2915-20. PubMed ID: 3502415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.
    Tamma PD; Rodriguez-Bano J
    Clin Infect Dis; 2017 Apr; 64(7):972-980. PubMed ID: 28362938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-(Methoxymethylene)penicillanic acid: inactivator of RTEM beta-lactamase from Escherichia coli.
    Brenner DG; Knowles JR
    Biochemistry; 1984 Nov; 23(24):5839-46. PubMed ID: 6098300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).
    Labia R; Lelievre V; Peduzzi J
    Biochim Biophys Acta; 1980 Feb; 611(2):351-7. PubMed ID: 6243991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.